Diuretics Flashcards
Proximal Tubule important for reabsorption of
Na-HCO3
NaCl
H2O
as well as AA’s, glucose, etc.
Where are the two main sites of K reabsorption?
Proximal convoluated tubule (65%) - compulsory
Distal convoluted tubule - regulated
Carbonic Anhydrase Inhibitors used for?
Used to be diuretic but now more for metabolic
Carbonic Anhydrase Inhibitors MOA
inhibit CA
decreased HCO3- reasorption in PCT
decreased HCO3- formation in kidney/RBC’s
Inhibition of titratable acid and NH4+ secretion
Ultimately leads to increased HCO3- excretion which pulls NaCl and H2O with it resulting in DIURESIS
Clinical indication of Carbonic anhydrase inhibitors
Glaucoma
Acute mountain sickness
Induce urinary alkalinization
Edema (combined with NKCC and NCC inhibitors)
Adverse Effects of Carbonic Anhydrase Inhibitors
Contraindicated in?
hyperchloremia metabolic acidosis
renal stones
renal loss of K
Cirrhosis (d/t increased NH4)
Osmotic Diuretic MOA
Main site of action?
freely filtered/poorly reabsobred
Increases tubular osmotic pressure = pulling water into tubule and keeping it there
Thin loop of Henle
Clinical Applications of Osmotic Diuretics (4)
Prophylaxis of acute renal failure
Cerebral edema
Dialysis dysequilibrium syndrome
Acute glaucoma attacks
Adverse effects of osmotic diuretics
ECV expansion - risk of pulmonary edema w/CHF
Hyponatremia/hypernatremia
Contraindications of Osmotic Diuretics
anuria - d/t kidney disease
impaired liver function
active cranial bleed
Osmotic Diuretics
MANNITOL
glycerin
isosorbide
urea
Carboinic ANhydrase Inhibitors
ACETAZOLAMIDE
dichlrophenamide
methazolamide
Loop Diuretics (NKCC Inhibitors)
FUROSEMIDE
bumetanide
ethacrynic acid
NKCC Inhibitors MOA
inhibit Na/K/2Cl cotransporter
inhibits reabsorption of solute from Thick Ascending Limb
Venodilation occurs - decreases RA and PCW pressures within minutes
Increase fractional Ca and Mg excretion - both through paracellular route
Clinical Indications of NKCC Inhibitors
Pulmonary edema
CHF
Acute Renal Failure
Hypercalcemia - (saline + loop diuretics)
MAJOR adverse effect of NKCC Inhibitors
HYPOKALEMIA
used extensively in CHF patients along with digoxin and other potassium sensitive drugs
NCC Inhibitors (Thiazides and Sulfonamides)
CHLORTHALIDONE
hydrochlorothiazide
metolazone
indapamide
NCC inhibitors MOA
Inhibit Distal convoluted tubule Na/Cl co-transporter
Decreases Ca excretion
Causes vasorelaxation
Clinical Applications of NCC INhibitors (thiazides/sulfonamides)
Hypertension
Edema control
Hypercalciuria
Nephrolithiasis
Nephrogenic diabetes insipidus
Inhibitors of renal epithelial Na channels
AMILORIDE
triamterene
Renal Epithelial Na Channel Inhibitors MOA
block Na channels in late distal convoluted tubule and cortical collecting ducts
causes MODEST natriuresis and prevention of K LOSS
Clinical indications of Renal Epithelial Na Channel Inhibitors
K-sparing agents in HYPOKALEMIC ALKALOSIS
in combo with thiazides/sulfonamides
Aldosterone receptor antagonists
SPIRONOLACTONE
eplerenone
Aldosterone antagonist MOA
antagonize aldosterone receptor
decrease Na reabsorption - natriuresis
decrease loss of K in exchange for Na